Qiagen reports financial growth, credits non-COVID products sales

LabPulse.com staff writers
Feb 10, 2022
2021 12 30 00 31 3981 Business Graph Money Stocks 400

Qiagen reported financial growth for the fourth quarter and full 2021 fiscal year, including sales from non-COVID products.

The company reported sales growth of 2% to $582 million for the fourth quarter. It also reported sales growth of 20% to $2.25 billion for the full year.

Qiagen also touted its 22% growth in constant exchange rates in non-COVID product sales, ahead of its 20% target. The company began its 2022 outlook for at least $2.07 billion in net sales, including double-digit constant exchange rate growth in non-COVID products versus 2021.

Latest in Infectious
Bacteria Mycobacterium Tuberculosis Social
Danaher cuts cost of rapid TB test after years of pressure from activists
September 21, 2023
Research Money Social
Day Zero Diagnostics completes $16M financing round
September 20, 2023
At-home or Lab-based STI testing/collection
Sponsored
At-home or Lab-based STI testing/collection
September 6, 2023
Lab Blood Tubes Social
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
September 18, 2023
Related Stories
2022 07 13 19 56 4243 3 D Monkeypox Infecting Cell 400
Enterovirus
Qiagen launches syndromic monkeypox test for research
2020 04 28 19 25 1337 Sequencing Dna Rna Pcr 400
PCR
Qiagen expands PCR portfolio, launches custom assay service
2021 01 12 23 44 3780 Blood Test Samples Lab 400
Collaboration
Qiagen expands QIAstat-Dx syndromic panel
At-home or Lab-based STI testing/collection
Sponsor Content
At-home or Lab-based STI testing/collection
More in Infectious
Danaher cuts cost of rapid TB test after years of pressure from activists
Danaher has cut the cost of one of its tuberculosis (TB) tests in less developed countries after years of public pressure to lower the price.
September 21, 2023
Bacteria Mycobacterium Tuberculosis Social
Day Zero Diagnostics completes $16M financing round
Day Zero Diagnostics has completed a $16 million financing round, executed as a convertible note.
September 20, 2023
Research Money Social
NIH starts early-phase trial of second-generation universal flu vaccine candidate
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
Needle Shot Vaccine Teenager Social
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
A research consortium led by Stellenbosch University in Stellenbosch, South Africa, was awarded 5 million euros ($5.3 million) from the EU Horizon Europe program for genomic research in combating epidemics in Africa.
September 18, 2023
Lab Blood Tubes Social
Moderna’s mRNA flu shot yields promising results in phase III trial
Moderna announced that its mRNA flu shot that is in development has met its primary endpoints in a phase III trial, generating a stronger immune response than a commercially available flu vaccine.
September 15, 2023
Vaccine Injection Woman Social
USP proposes synthetic alternative to horseshoe crab blood in endotoxin testing
The U.S. Pharmacopoeia (USP) has published draft guidelines on using a synthetic alternative to reagents derived from horseshoe crabs, advancing efforts to provide an alternative way of performing endotoxin testing.
August 31, 2023
Lab Blood Man Social
Gene expression test may improve diagnosis of febrile childhood diseases
A simple blood test based on patterns of gene expression could radically improve and speed up the diagnosis of febrile childhood diseases, say researchers.
August 30, 2023
Child Hospital Social
Raman spectroscopy slashes time to detect pathogens bound to magnetic beads
Raman spectroscopy can accelerate the detection of pathogens bound to microscopic magnetic beads, according to a paper that will be published in the Journal of Raman Spectroscopy.
August 28, 2023
Dynabeads, which are antibody-coated superparamagnetic beads, served as a strong Raman reporter for the simultaneous capture and detection of pathogenic bacterium such as Salmonella enterica. This image shows the Dynabeads (gray spheres) interacting with S. enterica bacterium (in green). The inset shows the Y-shaped antibodies coating the Dynabeads.
Nonprofit health system adopts Immunexpress test for detecting sepsis
FirstHealth of the Carolinas, a nonprofit health system licensed for four hospitals in North Carolina, will use Immunexpress’ SeptiCyte Rapid test to help differentiate sepsis-positive cases from patients with infection-negative systemic inflammation.
August 23, 2023
Bacteria Blood Sepsis Social
NIH names Jeanne Marrazzo to fill NIAID post vacated by Anthony Fauci
Marrazzo currently works as director of the Division of Infectious Diseases at the University of Alabama at Birmingham and is expected to take up her position as the director of the NIAID in the fall.
August 3, 2023
Nih Logo Social
PBD receives U.S. patent for phage-based tuberculosis diagnostic kit
PBD is using its expertise in phages to develop Actiphage, a test designed to detect the active mycobacteria that cause tuberculosis in blood samples.
August 1, 2023
Bacteriophage Social
Proliferation of infectious disease tests leading to misuse and misinterpretation: Report
The disconnect between changes in demand and capabilities can result in lab directors being asked to oversee testing that is outside of their areas of expertise. Additionally, there are more and more testing options.
July 28, 2023
Lab Test Antibody Social
Page 1 of 147
Next Page